Recent Posts
- Defence’s Successful Submission of an Investigational New Drug (IND) Application for ACCUTOX® as an Injectable Anticancer Treatment for Solid Tumors
- Defence’s Novel Accutoxtm Continues To Surprise On Results Against Cancer
- Delivery Of Encapsulated Accutoxtm-Chitosan Nanoparticles Triggers Complete Tumor Regression In Animals With Pre-Estabslihed Solid Lymphoma
- Defence To Present Three Of Its Leading Products At The Upcoming Festival Of Biologics In Basel, Switzerland
- Defence Announces Peer-Reviewed Publication Of Its Preclinical Data On Accum® As An Anti-Cancer Molecule In The Journal Of Cancer Science
Recent Comments